DriveItAway_Logo_4C Medium Size.jpg
DriveItAway Holdings, Inc. Partnerships & Growth Highlighted in Leading Automotive Trade Publication
July 24, 2024 08:33 ET | DriveItAway Holdings, Inc.
Philadelphia, PA, July 24, 2024 (GLOBE NEWSWIRE) -- - DriveItAway has forged four major partnerships so far in 2024, to enable it to rapidly scale sales, market share, and profits in its goal to...
TOMI.jpg
TOMI Environmental Solutions Secures $1.2 Million Contract with Enviro-Mist Inc. Driving SteraMist Growth in the Pharmaceutical Market
July 24, 2024 08:30 ET | TOMI Environmental Solutions, Inc.
FREDERICK, Md., July 24, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today...
IBS Logo Primary.jpg
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
July 24, 2024 08:30 ET | Intelligent Bio Solutions, Inc.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Tag.png
Nametag and Tines Bring AI-Powered Automated Identity Verification to Security and IT Teams Globally
July 24, 2024 08:30 ET | NAMETAG INC.
Nametag and Tines partner to help cybersecurity and information technology teams benefit from artificial intelligence and workflow automation.
mobiquity_technoliges_logo.jpg
Mobiquity Technologies and Adfuel to Elevate Digital Presence for Local Businesses
July 24, 2024 08:15 ET | Mobiquity Technologies, Inc.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (OTC: MOBQ) ("the Company"), a leading provider of next-generation data intelligence and advertising technologies, today...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
July 24, 2024 08:05 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Sunrun Customer Brian Foreman
Sunrun Launches Nation’s First Vehicle-To-Home Grid Support In Maryland Using Ford F-150 Lightning Trucks
July 24, 2024 08:00 ET | Sunrun Inc.
SAN FRANCISCO, July 24, 2024 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, is now operating the nation’s first vehicle-to-home...
Critical Response Group and Intrado Collaborate to Elevate Emergency Response and Enhance Situational Awareness Nationwide
July 24, 2024 08:00 ET | Critical Response Group
HAMILTON, N.J. and LONGMONT, Colo., July 24, 2024 (GLOBE NEWSWIRE) -- Critical Response Group (CRG), the nation’s leader in critical incident mapping data, and Intrado, a global leader in emergency...
Dreem3S Bedside
Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
July 24, 2024 07:30 ET | Beacon Biosignals
BOSTON and SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in at-home sleep monitoring and computational neurodiagnostics, today announced a strategic collaboration with...
SKYE Logo.png
Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints
July 24, 2024 06:00 ET | Skye Bioscience, Inc.
SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic...